Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyclohexyl salicylate promotes human hair growth and increases certain hair follicle stem cell progeny.

Medications for PCOS don't seem to raise heart disease risk.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Hair glycation can indicate long-term blood sugar levels and diabetic nerve issues.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Activating a bitter taste receptor in hair follicles can stop hair growth by increasing a specific growth factor.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

Dopaminergic neurons in the gut have distinct subtypes, some releasing both dopamine and acetylcholine.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Higher levels of the DP2 receptor may lead to hair loss.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Insulin-dependent diabetes alters hair's molecular structure, making it useful for studying diabetes effects.

A woman was diagnosed with Sheehan's syndrome and a rare complication of diabetes insipidus 33 years after symptoms began, improving with hormone therapy.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.